Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
4
×
boston blog main
4
×
boston top stories
life sciences
national blog main
national top stories
new york blog main
new york top stories
san francisco blog main
san francisco top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
sanofi
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
bristol-myers squibb
chronic kidney disease
fda
5am ventures
abbvie
abeona therapeutics
acc
acquisition
activist investor
aducanumab
affordable care act
agios pharmaceuticals
What
people
4
×
bio
roundup
abbvie’s
adu
ahead
american
approved
based
beats
benefits
best
better
bids
biofourmis
biogen
bucks
cancer
celebrate
chance
complicated
continue
corner
crash
day
days
debate
depression
dire
drug
eating
food
forward
good
greens
group
gurus
gut
healthcare
heart
Language
unset
Current search:
people
×
biotech
×
" boston blog main "
×
@xconomy.com
3 years ago
Bio Roundup: Pharma M&A, AbbVie’s Cancer Bet, Biofourmis Bucks & More
@xconomy.com
4 years ago
Novome Lands $33M to Tweak a Gut Microbe Into a Metabolic Therapy
@xconomy.com
5 years ago
Bio Roundup: Sage Postpartum Help, Biogen Bids Adu, Heart Beats & More
@xconomy.com
5 years ago
Bio Roundup: Trump’s Scalps, Policy Pressure, NASH Crash & More